刘珉 讲师，主治医师
硕士招生类型：专业型
硕士招生专业：外科学（神经外科）
博士招生类型：
博士招生专业：
所在院系：
联系方式：rodger_lm@163.com
课题组链接：
研究方向
主要任职
科研业绩

神经重症及其并发症的分子机制研究；脂质代谢组学；

同济大学附属东方医院神经外科科研主管，神经外科ICU主治医师，讲师。

毕业于上海交通大学医学院临床医学7年制英文班，日本九州大学医学博士，历任日本顺天堂大学医学部生化学教研室助理教授、客座助理教授。曾获得国际脂质生物学会****科学家奖、日本生化学会铃木玄一纪念奖等多项国际学术奖励，发表SCI论文10余篇，入选上海市科委浦江人才计划，上海市卫计委青年医师培养计划，承担国家自然基金项目、上海市浦东新区卫建委面上项目等各级研究项目。目前主要从事神经重症及其并发症的分子机制研究。
主要研究方向：神经重症及其并发症的分子机制研究；脂质代谢组学；
主要承担课题：
1. 国家自然科学基金青年项目，**，白三烯B4第二受体（BLT2）调控血管内皮功能参与糖尿病慢性皮肤溃疡的作用机制研究, 2017.01-2019.12，19万元，在研，主持
2. 上海申康医院发展中心慢性病综合防治项目，SHDC**, 社区糖尿病移动医疗标准化诊疗模式的推广研究，2015.12-2018.11，20万元，已结题，参加
3. 上海市科学技术委员会浦江人才计划，15PJ**，白三烯B4第二受体（BLT2）调控气道上皮屏障功能参与支气管哮喘发病的机制研2015.07-2017.06，20万元，已结题，主持
主要发表文章：
(1) Xu Siyi#, Liu M#,Gao Yang, Cao Yang, Bao Jingang, Lin Yingying, Wang Yong, Luo Qizhong, JiangJiyao, Zhong Chunlong*, Acute histopathological responses and long-termbehavioral outcomes in mice with graded controlled cortical impact injury.Neural Regen Res, 2019; 14(6):973~997
(2) Liu Min#*, ShenJuan#, Yuan Huimin, Chen Fengling*, Song Huidong, Qin Hui, Li Yanqin, Xu Jiabo,Ye Qing, Li Shengxian, Saeki Kazako, Yokomizo Takehiko. Leukotriene B4 receptor2 regulates the proliferation, migration and barrier integrity of bronchialepithelial cells. J Cel Physio, 2018, 233(8):6117~6124
(3) Liu Min, YokomizoTakehiko*. The role of leukotrienes in allergicdiseases. Allergol Int, 2015, 64(1):17~26
(4) Liu M,Saeki Kazuko, Matsunobu Takehiko, Okuno Toshiaki, Koga Tomoaki, Sugimoto Yukihiko,Yokoyama Cieko, Nakamizo Satoshi, Kabashima Kenji, Narumiya Shuh, Shimizu Takao,Yokomizo Takehiko*, 12-hydroxyheptadecatrienoic acidpromotes epidermal wound healing by accelerating keratinocyte migration via theBLT2 receptor. J Exp Med, 2014, 211(6):1063~1078
(5) Liu Min,Yanase Toshihiko, Tanaka Tomoko, Fan Wuqiang, Nomura Masatoshi, Kawate Hisaya,Okabe Taijiro, Takayanagi Ryoichi, Nawata Hajime^*. A novel syntheticandrogen receptor ligand, S42, works as a selective androgen receptor modulatorand possesses metabolic effects with little impact on the prostate.Endocrinology, 2009, 150(12):5606~5616
(1) Xu Siyi^#,Liu M^#, Gao Yang, Cao Yang, Bao Jingang, Lin Yingying, Wang Yong,Luo Qizhong, Jiang Jiyao, Zhong Chunlong^*, Acute histopathologicalresponses and long-term behavioral outcomes in mice with graded controlledcortical impact injury. Neural Regen Res, 2019; 14(6):973~997
(2) Liu Min^#*,Shen Juan^#, Yuan Huimin, Chen Fengling^*, Song Huidong,Qin Hui, Li Yanqin, Xu Jiabo, Ye Qing, Li Shengxian, Saeki Kazako, YokomizoTakehiko. Leukotriene B4 receptor 2 regulates the proliferation, migration andbarrier integrity of bronchial epithelial cells. J Cel Physio, 2018,233(8):6117~6124
(3) Liu Min,Yokomizo Takehiko^*. The role of leukotrienes in allergic diseases.Allergol Int, 2015, 64(1):17~26
(4) LiuM, Saeki Kazuko, Matsunobu Takehiko, Okuno Toshiaki, Koga Tomoaki, SugimotoYukihiko, Yokoyama Cieko, Nakamizo Satoshi, Kabashima Kenji, Narumiya Shuh,Shimizu Takao, Yokomizo Takehiko^*, 12-hydroxyheptadecatrienoic acidpromotes epidermal wound healing by accelerating keratinocyte migration via theBLT2 receptor. J Exp Med, 2014, 211(6):1063~1078
(5) Liu Min,Yanase Toshihiko, Tanaka Tomoko, Fan Wuqiang, Nomura Masatoshi, Kawate Hisaya,Okabe Taijiro, Takayanagi Ryoichi, Nawata Hajime^*. A novel syntheticandrogen receptor ligand, S42, works as a selective androgen receptor modulatorand possesses metabolic effects with little impact on the prostate.Endocrinology, 2009, 150(12):5606~5616